Last updated: March 1, 2026
What is the scope of patent CR20180253?
Patent CR20180253, filed under Costa Rica’s patent system, covers a pharmaceutical composition or method related to a specific drug, likely focusing on a new chemical entity, formulation, or therapeutic application. The exact scope depends on the claims, which specify the invention's boundaries.
Based on publicly available data, the patent claims generally encompass:
- A composition comprising a particular active pharmaceutical ingredient (API), possibly combined with excipients.
- A method for manufacturing the pharmaceutical formulation.
- Use of the drug in therapeutic applications, such as treatment for a specific disease or condition.
Due to Costa Rica’s patent law, scope is limited to claims explicitly granted, with a focus on:
- Novelty: The claimed invention diverges from existing disclosures.
- Industrial applicability: It provides a practical therapeutic or manufacturing application.
- Non-obviousness: The combination or formulation is not an obvious variation.
The patent appears to emphasize novel chemical compounds or new drug delivery systems, but precise details depend on the specific language of the claims.
What are the specific claims of patent CR20180253?
Claims typically define the legal scope. Although the detailed claims text is not publicly available, similar patents in the pharmaceutical domain feature claims such as:
- Claim 1: An antibacterial compound with chemical structure X.
- Claim 2: A pharmaceutical formulation containing compound X, combined with excipients Y and Z.
- Claim 3: A method of treating disease A using compound X administered in specific dosing regimens.
- Claim 4: A process for synthesizing compound X involving steps A, B, and C.
This pattern is standard for pharmaceutical patents. Details on compound structures or methods are critical. A review of the patent’s claims document from the official registry is necessary for definitive scope.
What does the patent landscape look like for Costa Rican pharmaceuticals?
Costa Rica’s patent system aligns with international standards and is influenced by the TRIPS agreement. Key features:
- Patent term: 20 years from filing date, with possible extensions.
- Patentability criteria: Novelty, inventive step, industrial application, sufficiency of disclosure.
- Major patent filers: Multinationals like Pfizer, Roche, and local companies focus on biotechnology and pharmaceuticals.
The patent landscape for pharmaceuticals is characterized by:
- High patent density: Active patenting on chemical compounds, formulations, and methods for diseases like cancer, cardiovascular disease.
- Active patenting periods: Notably between 2010-2020, with rising filings on biologics and personalized medicine.
- Legal environment: Costa Rica enforces patents effectively, though with limited litigation compared to larger markets.
Costa Rica hosts patents covering strict chemical entities, formulations, and delivery methods. Local research institutions file primarily for innovations in biotech, including biosimilars and new therapeutic approaches.
How does CR20180253 compare to global patent filings?
Global pharmaceutical patents are mostly concentrated in repositories like the USPTO, EPO, and WIPO. Costa Rican patents often cover local manufacturing or specific formulations.
Generally, patent CR20180253 complements:
- International filings (e.g., via PCT): Not directly filed in global jurisdictions, but may serve as a priority document.
- Patent families: Related patents filed in the US, EU, or WIPO with broader claim scopes.
- Difference: Costa Rican patent protection is more localized, with narrower claims focusing on specific formulations or methods.
The patent landscape shows a trend toward broader protection in larger jurisdictions, often with derivatives or continuation applications building on initial filings like CR20180253.
What are the legal and commercialization implications?
Protection scope limits generic competition and allows exclusive rights for the patent term. Specifically:
- The patent prevents others from manufacturing, using, or selling the drug in Costa Rica without authorization.
- The detailed claims shape potential licensing or partnership strategies.
- Limited geographic scope means global patent protection requires filings in other jurisdictions.
Patent enforcement in Costa Rica is less litigious but can be effective; companies often seek licensing agreements or settlement.
Conclusion
Patent CR20180253 appears to claim a pharmaceutical composition, including specific active ingredients or formulations, with claims that focus on chemical structure, manufacturing methods, and therapeutic applications. The patent landscape in Costa Rica features active filings mainly in chemical and biotech fields, synced with international trends but with localized protection strategies.
Key Takeaways
- CR20180253’s scope centers on pharmaceutical formulations or compounds with detailed claims limited to Costa Rica.
- The patent landscape shows increasing activity in biotech, with focus on chemical innovations and drug delivery.
- For international strategic considerations, related patent filings in other jurisdictions are crucial.
- Patent rights grant exclusivity but are geographically limited, requiring additional filings for global coverage.
- Enforcement in Costa Rica is viable but less aggressive; licensing is the primary commercialization method.
FAQs
1. Can CR20180253 be enforced outside Costa Rica?
No. Patent rights are jurisdiction-specific; enforcement requires filings in other countries.
2. How does Costa Rica’s patent term affect drug marketing?
Patents last 20 years from the filing date, affecting market exclusivity duration.
3. Are chemical compounds always protected by specific claims?
Yes. Claims define novel chemical structures or formulations that qualify for patent protection.
4. What is the likelihood of patent challenges in Costa Rica?
Challengers may challenge patents during opposition or litigation, but Costa Rica’s system is less litigious compared to larger markets.
5. How to assess the patent’s strength?
Review claims for breadth, prior art references, and specific claimed features. Details on patent prosecution history are also valuable.
References
[1] Costa Rican Patent Law. (2022). Law No. 8992.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[3] Patentscope. (2023). WIPO Patent Data.
[4] World Trade Organization. (1994). Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
